설명
Multi-omics profiling of fecal microbiota reveals species-level compositional shifts between IBS symptom exacerbation and baseline states. Certain bacterial taxa show significant abundance changes associated with diarrhea-predominant IBS flares.
Figure 2
ChartSource Paper
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.Cite This Figure
![Figure 2: Multi-omics profiling of fecal microbiota reveals species-level compositional shifts between IBS symptom exacerbation and baseline states. Certain bacterial taxa show significant abundance changes associated with diarrhea-predominant IBS flares.]() > Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." *Journal of gastroenterology*, 2022. PMID: [35908139](https://pubmed.ncbi.nlm.nih.gov/35908139/)
<figure> <img src="" alt="Multi-omics profiling of fecal microbiota reveals species-level compositional shifts between IBS symptom exacerbation and baseline states. Certain bacterial taxa show significant abundance changes associated with diarrhea-predominant IBS flares." /> <figcaption>Figure 2. Multi-omics profiling of fecal microbiota reveals species-level compositional shifts between IBS symptom exacerbation and baseline states. Certain bacterial taxa show significant abundance changes associated with diarrhea-predominant IBS flares.<br> Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." <em>Journal of gastroenterology</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35908139/">35908139</a></figcaption> </figure>